fluconazole has been researched along with framycetin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Biswas, NR; Das, GK; Mittal, D; Mohanty, S; Panda, A | 1 |
| Auckenthaler, R; Garbino, J; Hugonnet, S; Lew, DP; Pittet, D; Romand, JA | 1 |
| Dayanir, V; Ertabaklar, H; Ertuğ, S; Türk, M; Walochnik, J | 1 |
| Ehrenreich, IM; Foree, R; Matsui, T; Mullis, MN; Schell, R | 1 |
1 trial(s) available for fluconazole and framycetin
| Article | Year |
|---|---|
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.
Topics: Aged; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Chi-Square Distribution; Critical Illness; Decontamination; Digestive System; Double-Blind Method; Female; Fluconazole; Humans; Intensive Care Units; Male; Neomycin; Polymyxins; Prospective Studies; Risk Factors; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Vancomycin | 2002 |
7 other study(ies) available for fluconazole and framycetin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Therapy of acanthamoeba keratitis--an experimental study.
Topics: Acanthamoeba Keratitis; Animals; Biguanides; Female; Fluconazole; Male; Neomycin; Povidone-Iodine; Rabbits | 2000 |
Acanthamoeba keratitis due to Acanthamoeba genotype T4 in a non-contact-lens wearer in Turkey.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Benzamidines; Biguanides; Contact Lenses; Disinfectants; Fluconazole; Genotype; Humans; Male; Neomycin; Risk Factors; Turkey | 2007 |
The complex underpinnings of genetic background effects.
Topics: Chromosome Mapping; Epistasis, Genetic; Fluconazole; Gene Expression Regulation, Fungal; Gene Knockout Techniques; Gene-Environment Interaction; Genetic Background; Genotype; Mutation; Neomycin; Saccharomyces cerevisiae | 2018 |